CASE REPORT
KEYWORDS
ABSTRACT
Takayasu arteritis involves the aorta and its major branches. The treatment of TA usually includes immunosuppressive therapy and endovascular procedures. We report the case of a 32-year old patient who was treated with immunosuppressive agents before and after angioplasty. Angioplasty was performed after ESR and CRP decreased. In our opinion the efficacy of invasive treatment depends on immunosuppressive therapy.
REFERENCES (11)
1.
Numano F. Introduction remarks for this special issue on Takayasu arteritis. Heart Vessels 1982; 7: 3-5. .
2.
Numano F. The story of Takayasu arteritis. Rheumatology 2002; 41: 103-106. .
3.
Krishna MV, Namratha S, et al. Takayasu’s Arteritis – Stroke as an Initial Presentation. Journal Indian Academy of Clinical Medicine 2004; 5: 274-276. .
4.
Koide K. Takayasu arteritis in Japan. Heart Vessels 1992; 7: 48-54. .
5.
Wardyn KA, Życińska K. Pierwotne układowe zapalenia naczyń. Wyd. Urban & Partner 2004; 205-208. .
6.
Reumatologia kliniczna. Zimmermann-Górska I (red.). Wyd. Lek. PZWL, Warszawa 2008; 1015. .
7.
Standardy postępowania opracowane przez PTR. Dostępne na: stud.pam.szczecin.pl/.../reumatologia/reumatologia%20-%20standardy.doc .
8.
Pil-Ki Min, Sungha Park, et al. Endovascular Therapy Combined With Immunosuppressive Treatment for Occlusive Arterial Disease in Patients With Takayasu’s. Arteritis J Endovasc Ther 2005; 12: 28-34. .
9.
Fields CE, Bower TC, Cooper LT. Takayasu's arteritis: Operative results and influence of disease activity. JVasc Surg 2006; 43: 64-71. .
10.
Byung-Ju S, Ho-Joong Y, et al. Takayasu’s Arteritis Treated by Percutaneous Transluminal Angioplasty with Stenting in the Descending Aorta. Korean Med Sci 2008; 23: 551-555. .
11.
Min-Ho Song, Nakayama, et al. Aortic root aneurysm in Taka- yasu arteritis syndrome: Exploration in active phase and repair in inactive phase. J Thoracic Cardiovasc Surg 2008; 136: 1084-1085.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.